REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $106,504,922.64

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$933.02

▲ +4.12 (0.44%)

As of 10/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00
11/22/2021	George L. Sing	Director	Sell	2,000	$657.50	$1,315,000.00
11/18/2021	George L. Sing	Director	Sell	4,000	$650.00	$2,600,000.00
11/17/2021	Robert E. Landry	CFO	Sell	681	$645.08	$439,299.48
11/16/2021	Andrew J. Murphy	EVP	Sell	7,167	$647.17	$4,638,267.39
11/16/2021	George L. Sing	Director	Sell	6,000	$656.26	$3,937,560.00

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/25/2024	Oak Harvest Investment Services	2,779	$2.92M	0.4%	+25.6%	0.003%
10/25/2024	SteelPeak Wealth LLC	1,108	$1.17M	0.1%	+1.5%	0.001%
10/25/2024	Pinnacle Associates Ltd.	66,965	$70.40M	1.1%	+0.9%	0.061%
10/25/2024	First Trust Direct Indexing L.P.	3,842	$4.04M	0.2%	+3.3%	0.003%
10/25/2024	New York State Teachers Retirement System	100,427	$105.57M	0.2%	+0.9%	0.091%
10/25/2024	Loring Wolcott & Coolidge Fiduciary Advisors LLP MA	109,481	$115.09M	1.0%	+5.6%	0.099%
10/25/2024	Adams Diversified Equity Fund Inc.	21,700	$22.81M	0.8%	-32.8%	0.020%
10/25/2024	Great Diamond Partners LLC	335	$0.35M	0.1%	-43.1%	0.000%
10/25/2024	Avitas Wealth Management LLC	330	$0.35M	0.0%	-6.8%	0.000%
10/25/2024	Fidelis Capital Partners LLC	501	$0.53M	0.1%	-6.2%	0.000%
10/25/2024	GW Henssler & Associates Ltd.	18,068	$18.99M	1.1%	-2.6%	0.016%
10/25/2024	Strategic Blueprint LLC	4,087	$4.30M	0.3%	-0.9%	0.004%
10/25/2024	Cutter & CO Brokerage Inc.	7,665	$8.06M	1.8%	-1.4%	0.007%
10/25/2024	Integrated Advisors Network LLC	197	$0.21M	0.0%	-5.3%	0.000%
10/25/2024	China Universal Asset Management Co. Ltd.	14,766	$15.52M	1.7%	+54.6%	0.013%
10/25/2024	Traynor Capital Management Inc.	22,390	$23.54M	1.4%	+10.2%	0.020%
10/25/2024	abrdn plc	186,711	$196.39M	0.4%	+4.8%	0.169%
10/24/2024	Orrstown Financial Services Inc.	225	$0.24M	0.1%	N/A	0.000%
10/24/2024	Nisa Investment Advisors LLC	29,742	$31.27M	0.2%	+33.8%	0.027%
10/24/2024	Concord Wealth Partners	989	$1.04M	0.2%	+9.9%	0.001%
10/24/2024	Welch Group LLC	360	$0.38M	0.0%	+71.4%	0.000%
10/24/2024	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	1,829	$1.92M	0.3%	+8.6%	0.002%
10/24/2024	Smithbridge Asset Management Inc. DE	5,806	$6.10M	1.1%	+75.8%	0.005%
10/24/2024	Tower View Wealth Management LLC	2,447	$2.57M	1.4%	+5.9%	0.002%
10/24/2024	Baker Tilly Wealth Management LLC	736	$0.77M	0.3%	+22.9%	0.001%
10/24/2024	FCG Investment Co	1,024	$1.08M	0.7%	+26.0%	0.001%
10/24/2024	Cavalier Investments LLC	2,519	$2.65M	0.8%	+5.8%	0.002%
10/24/2024	Pointe Capital Management LLC	341	$0.36M	0.2%	N/A	0.000%
10/24/2024	Custom Index Systems LLC	285	$0.30M	0.2%	-13.1%	0.000%
10/24/2024	Sterling Investment Advisors Ltd.	3,047	$3.20M	0.8%	-8.4%	0.003%
10/24/2024	J.W. Cole Advisors Inc.	802	$0.84M	0.0%	+11.5%	0.001%
10/24/2024	State of Alaska Department of Revenue	19,294	$20.28M	0.2%	-7.2%	0.018%
10/24/2024	Valley National Advisers Inc.	1,280	$1.35M	0.2%	-11.6%	0.001%
10/24/2024	Frank Rimerman Advisors LLC	597	$0.63M	0.0%	+3.5%	0.001%
10/24/2024	Clear Harbor Asset Management LLC	2,415	$2.54M	0.2%	+0.9%	0.002%
10/24/2024	DekaBank Deutsche Girozentrale	211,207	$218.66M	0.4%	-1.2%	0.192%
10/24/2024	Modera Wealth Management LLC	8,447	$8.88M	0.1%	-3.0%	0.008%
10/24/2024	Boston Trust Walden Corp	1,453	$1.53M	0.0%	-1.4%	0.001%
10/24/2024	NorthCrest Asset Manangement LLC	11,076	$11.64M	0.4%	+2.5%	0.010%
10/24/2024	Forsta AP Fonden	24,500	$25.76M	0.2%	+9.9%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	45,581	$46.90M	0.2%	+19.5%	0.041%
10/23/2024	Louisiana State Employees Retirement System	14,300	$15.03M	0.3%	-2.1%	0.013%
10/23/2024	Allworth Financial LP	709	$0.75M	0.0%	+7.3%	0.001%
10/23/2024	Elwood & Goetz Wealth Advisory Group LLC	492	$0.52M	0.1%	N/A	0.000%
10/23/2024	Mediolanum International Funds Ltd	4,225	$4.40M	0.1%	-71.3%	0.004%
10/23/2024	Ballentine Partners LLC	1,062	$1.12M	0.0%	+4.9%	0.001%
10/23/2024	Freedom Day Solutions LLC	2,449	$2.57M	0.8%	+0.8%	0.002%
10/23/2024	Heritage Oak Wealth Advisors LLC	353	$0.37M	0.2%	N/A	0.000%
10/23/2024	Busey Bank	1,563	$1.64M	0.1%	-12.7%	0.001%
10/23/2024	Silver Oak Securities Incorporated	929	$0.97M	0.1%	+523.5%	0.001%
10/23/2024	Moody Lynn & Lieberson LLC	267	$0.28M	0.0%	-73.9%	0.000%
10/23/2024	E. Ohman J or Asset Management AB	4,430	$4.66M	0.1%	-5.9%	0.004%
10/23/2024	Tectonic Advisors LLC	712	$0.75M	0.0%	-9.2%	0.001%
10/23/2024	Dakota Wealth Management	1,327	$1.40M	0.0%	-4.8%	0.001%
10/23/2024	Assenagon Asset Management S.A.	172,859	$181.72M	0.3%	+34.6%	0.157%
10/23/2024	IFM Investors Pty Ltd	23,285	$24.48M	0.2%	+0.1%	0.021%
10/23/2024	Moody Aldrich Partners LLC	271	$0.29M	0.1%	-14.5%	0.000%
10/23/2024	CENTRAL TRUST Co	1,445	$1.52M	0.0%	-18.7%	0.001%
10/23/2024	Hennion & Walsh Asset Management Inc.	3,007	$3.16M	0.1%	+21.1%	0.003%
10/23/2024	Global Assets Advisory LLC	531	$0.56M	0.3%	N/A	0.000%
10/23/2024	Great Lakes Retirement Inc.	2,542	$2.67M	0.3%	+13.6%	0.002%
10/23/2024	Brighton Jones LLC	262	$0.28M	0.0%	-71.5%	0.000%
10/22/2024	International Assets Investment Management LLC	880,939	$926.08M	0.1%	+86,013.3%	0.799%
10/22/2024	Axecap Investments LLC	1,994	$2.10M	1.6%	N/A	0.002%
10/22/2024	Heartland Bank & Trust Co	608	$0.64M	0.3%	-2.6%	0.001%
10/22/2024	McAdam LLC	2,644	$2.78M	0.2%	-0.7%	0.002%
10/22/2024	Hartford Investment Management Co.	6,686	$7.03M	0.2%	-1.7%	0.006%
10/22/2024	Commerzbank Aktiengesellschaft FI	402	$0.42M	0.0%	+74.0%	0.000%
10/22/2024	Lecap Asset Management Ltd.	981	$1.03M	0.2%	N/A	0.001%
10/22/2024	Marietta Wealth Management LLC	7,653	$8.05M	1.2%	+0.4%	0.007%
10/22/2024	GAM Holding AG	2,759	$2.90M	0.2%	+6.6%	0.003%
10/22/2024	Private Advisor Group LLC	5,361	$5.64M	0.0%	+6.0%	0.005%
10/22/2024	Westhampton Capital LLC	893	$0.94M	0.5%	+1.7%	0.001%
10/22/2024	Leo Wealth LLC	1,011	$1.06M	0.1%	+12.0%	0.001%
10/22/2024	Signaturefd LLC	2,365	$2.49M	0.0%	+1.0%	0.002%
10/22/2024	Sequoia Financial Advisors LLC	1,740	$1.83M	0.0%	+14.3%	0.002%
10/21/2024	Argus Investors Counsel Inc.	1,841	$1.94M	1.3%	+18.7%	0.002%
10/21/2024	Ledyard National Bank	6,391	$6.72M	0.6%	-2.9%	0.006%
10/21/2024	Plimoth Trust Co. LLC	837	$0.88M	0.2%	-7.8%	0.001%
10/21/2024	Western Financial Corp CA	1,703	$1.79M	1.0%	-6.4%	0.002%
10/21/2024	Northwest Investment Counselors LLC	184	$0.19M	0.0%	N/A	0.000%
10/21/2024	Retirement Guys Formula LLC	1,278	$1.34M	0.6%	+7.9%	0.001%
10/21/2024	Cassia Capital Partners LLC	751	$0.79M	0.5%	-7.9%	0.001%
10/21/2024	Prentiss Smith & Co. Inc.	2,037	$2.14M	1.4%	-2.7%	0.002%
10/21/2024	Crew Capital Management Ltd.	766	$0.81M	0.6%	N/A	0.001%
10/21/2024	Bellecapital International Ltd.	13,598	$14.30M	2.8%	+1.7%	0.012%
10/21/2024	Koss Olinger Consulting LLC	353	$0.37M	0.0%	+7.3%	0.000%
10/19/2024	Allspring Global Investments Holdings LLC	57,121	$60.05M	0.1%	+0.3%	0.052%
10/19/2024	OLD National Bancorp IN	218	$0.23M	0.0%	-21.6%	0.000%
10/19/2024	Cyndeo Wealth Partners LLC	749	$0.79M	0.1%	-21.0%	0.001%
10/19/2024	Schaper Benz & Wise Investment Counsel Inc. WI	18,114	$19.04M	1.5%	+1.1%	0.016%
10/19/2024	New Century Financial Group LLC	208	$0.22M	0.1%	-30.2%	0.000%
10/18/2024	Resonant Capital Advisors LLC	370	$0.39M	0.0%	+6.3%	0.000%
10/18/2024	Veracity Capital LLC	5,672	$5.96M	2.3%	-2.4%	0.005%
10/18/2024	AA Financial Advisors LLC	386	$0.41M	0.1%	+11.9%	0.000%
10/18/2024	TriaGen Wealth Management LLC	1,334	$1.40M	0.5%	N/A	0.001%
10/18/2024	Raymond James & Associates	82,006	$86.21M	0.1%	+10.5%	0.074%
10/18/2024	Slow Capital Inc.	12,355	$12.99M	2.0%	+2.0%	0.011%
10/18/2024	Friedenthal Financial	48	$50K	0.0%	N/A	0.000%
10/18/2024	First Citizens Bank & Trust Co.	277	$0.29M	0.0%	-4.2%	0.000%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $933.02

$930.23

$943.83

50 Day Range

MA: $1,088.44

$928.90

$1,201.76

52 Week Range

Now: $933.02

$769.19

$1,211.20

Volume

547,777 shs

Average Volume

504,705 shs

Market Capitalization

$102.86 billion

P/E Ratio

24.71

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
N Anthony Coles (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
International Assets Investment Management LLC — 0.80%
DekaBank Deutsche Girozentrale — 0.19%
abrdn plc — 0.17%
Assenagon Asset Management S.A. — 0.16%
Swedbank AB — 0.14%
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA — 0.10%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Adams Diversified Equity Fund Inc.
Mediolanum International Funds Ltd
Bleakley Financial Group LLC
Perpetual Ltd
Handelsbanken Fonder AB
Boston Common Asset Management LLC
DekaBank Deutsche Girozentrale
State of Alaska Department of Revenue
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
International Assets Investment Management LLC
Assenagon Asset Management S.A.
Connective Portfolio Management LLC
Swedbank AB
Generate Investment Management Ltd
abrdn plc
Raymond James & Associates
Nisa Investment Advisors LLC